Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,79 CAD | -1,19% | -1,36% | +11,56% |
22/03 | KNIGHT THERAPEUTICS INC. : RBC Capital Markets nog altijd een koopadvies | ZM |
21/03 | Knight Therapeutics rapporteert resultaten voor het vierde kwartaal | MT |
Vakgebied
Aantal werknemers: 725
Verkoop per activiteit
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical Products, Consumer Health Products and Medical Devices
100,0
%
| 294 | 100,0 % | 328 | 100,0 % | +11,80% |
Verkoop per regio
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Brazil
51,3
%
| 135 | 45,9 % | 168 | 51,3 % | +24,86% |
Rest of Latin America
16,8
%
| 40 | 13,7 % | 55 | 16,8 % | +37,17% |
Colombia
13,6
%
| 46 | 15,7 % | 45 | 13,6 % | -3,24% |
Argentina
7,3
%
| 48 | 16,4 % | 24 | 7,3 % | -49,95% |
Canada
6,0
%
| 11 | 3,9 % | 20 | 6,0 % | +73,39% |
Other
5,0
%
| 13 | 4,4 % | 16 | 5,0 % | +26,27% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Samira Sakhia
CEO | Chief Executive Officer | 55 | 01-11-13 |
Jonathan Goodman
FOU | Founder | 56 | 01-11-13 |
Arvind Utchanah
DFI | Director of Finance/CFO | - | 20-06-16 |
Leopoldo Bosano
COO | Chief Operating Officer | - | - |
Monica Percario
CTO | Chief Tech/Sci/R&D Officer | - | - |
Susan Emblem
HRO | Human Resources Officer | - | 01-10-20 |
Amal Khouri
PRN | Corporate Officer/Principal | - | 01-08-14 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
James Gale
BRD | Director/Board Member | 74 | 06-01-14 |
Jonathan Goodman
FOU | Founder | 56 | 01-11-13 |
Robert N. Lande
BRD | Director/Board Member | 61 | 01-01-13 |
Samira Sakhia
CEO | Chief Executive Officer | 55 | 01-11-13 |
Director/Board Member | 48 | 01-01-20 | |
Michael Tremblay
BRD | Director/Board Member | 71 | 01-01-19 |
Janice Murray
BRD | Director/Board Member | 58 | 01-01-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 101 186 861 | 54 193 855 ( 53,56 %) | 0 | 53,56 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
1 153 897 | 10.42% | 301 167 $ |
Bedrijfsgegevens
Knight Therapeutics, Inc.
3400 de Maisonneuve West Suite 1055
H3Z 3B8, Montréal
+514-484-4483
http://www.gud-knight.comSector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,56% | 426 mln. | |
+10,08% | 9,12 mld. | |
-15,94% | 4,8 mld. | |
+18,47% | 3,72 mld. | |
+1,89% | 3,8 mld. | |
+28,61% | 2,58 mld. | |
-24,63% | 2,36 mld. | |
-29,37% | 2,11 mld. | |
+2,55% | 1,86 mld. | |
-0,50% | 1,64 mld. |